GSK has shared some exciting news about a new, more environmentally friendly version of their popular Ventolin inhaler. This new inhaler uses a different propellant called HFA-152a, which is better for the environment. The company has completed a large-scale study to make sure this new inhaler works just as well as the current one. The results show that it is just as safe and effective. Kaivan Khavandi, a senior leader at GSK, said that this new inhaler could reduce greenhouse gas emissions by a huge 92% per inhaler. This is a big deal because inhalers like Ventolin make up a large part of GSK’s total carbon footprint. The data from this study will be used to apply for regulatory approval. If all goes well, this new inhaler could be available starting in 2026. It will be made using advanced technologies at GSK’s facility in Évreux, France. Professor Ashley Woodcock, a respiratory medicine expert, pointed out that many patients prefer the metered dose inhalers (MDIs) like Ventolin. He believes that these data will allow patients to continue using their preferred inhaler while also helping the environment. This is an important step towards meeting global climate targets and taking care of patients. To support the pharmaceutical industry’s goal of reaching net-zero emissions, it’s important to continue supplying the necessary materials for making these inhalers during the transition period.